Clicky

Mind Medicine (MindMed) Inc.(MNMD)

Description: Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.


Keywords: Drugs Entheogens Psychoactive Drugs Drug Development Psychedelic Drug Ibogaine Mental Illness N Dimethyltryptamine Tabernanthe Iboga

Home Page: www.mindmed.co

MNMD Technical Analysis

One World Trade Center
New York, NY 10007
United States
Phone: 212 220 6633


Officers

Name Title
Mr. Robert Barrow CEO & Director
Dr. Miriam Halperin Wernli Ph.D. Exec. Pres
Dr. Daniel Rollings Karlin M.A., M.D. Chief Medical Officer
Dr. Scott M. Freeman M.D. Co-Founder & Clinical Advisor
Mr. Leonard Latchman Co-founder
Mr. Schond L. Greenway Chief Financial Officer
Ms. Carrie F. Liao CPA, CGMA VP, Corp. Controller & Accounting Principal
Ms. Wong Hu J.D. Chief Legal Officer & Corp. Sec.
Dr. Francois P. Lilienthal M.B.A., M.D. Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.658
Price-to-Sales TTM: 0
IPO Date: 2020-03-03
Fiscal Year End: December
Full Time Employees: 41
Back to stocks